Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

AGTC enrols first patient of second cohort for XLRP trial

Fundus of patient with retinitis pigmentosa, mid stage. Credit: Hamel; licensee BioMed Central Ltd.



Go Top